|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial显示文摘 | Mark A. Socinski Igor Bondarenko Nina A. Karaseva Anatoly M. Makhson Igor Vynnychenko Isamu Okamoto Jeremy K. Hon Vera Hirsh Paul Bhar Hui Zhang Jose L. Iglesias Markus F. Renschler | 2012 | Journal of Clinical Oncology2012，，17： | 3 |
| 2 | Fluorouracil,leucovorin,and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer显示文摘 | Bokemeyer C Bondarenko I Makhson A | | Journal of Clinical Oncology0，，： | 2 |
| 3 | Cetuximab plus 5- FU/FA/oxaliplutin (FOLFOX-4) versus FOLFOX-4 in the first-line treaanent of metastatic colorectal cancer (mCRC) : OPUS, a randomized phase II study显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2007 | J Clin Oncol2007，，： | 1 |
| 4 | Fluorouracil, leu- covorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer 显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2009 | J Clin Oncol2009，27，5： | 1 |
| 5 | Phase ] study of bevaci- zumab in combination with trastuzumab and capecitabine as first-linetreatment for HER-2-positive locally recurrent or metastatic breast cancer显示文摘 | Martin M Makhson A Gligorov J | 2012 | Oncologist2012，17，4： | 1 |
| 6 | Fluoro- uracil, leucovorin, and oxaliplatin with and without ce- tuximab in the first-line treatment of metastatic colorectal cancer显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2009 | J Clin Oncol2009，27，5： | 1 |
| 7 | Cetuximab plus 5-FU/ FA/ oxaliplatin ( FOLFOX-4 ) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC) : OPUS, a randomized phase Ⅱ study 显示文摘 | BOKEMEYER C BONDARENKO I MAKHSON A | 2007 | J Clin Oncol2007，25，18： | 1 |
| 8 | Fluo-rouracil,leucovorin,and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorec-tal cancer显示文摘 | Bokemeyer C Bondarenko I Makhson A | | 0，，75： | 1 |
| 9 | Fluorouracil,leucovorin,and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer显示文摘 | Bokeermeyer C Bondarenko I Makhson A | 2009 | J Clin Oncol2009，27，5： | 1 |
| 10 | Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the firstline treatment of metastatic colorectal cancer 显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2009 | J Clin Oncol2009，27，5： | 1 |
| 11 | Fluoronracil leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer 显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2012 | J Clin Onc012012，27，5： | 1 |
| 12 | Fluorouracil,leucovorin,and oxaliplatin with and without cetuximab in the firstline treatment of metastatic colorectal cancer显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2009 | J Clin Oncol2009，27，5： | 1 |
| 13 | chon- droblastoma显示文摘 | Bulycheva IV Semenov LA Makhson AN | 2007 | Arkh Patol2007，69，3： | 1 |
| 14 | Fluorouracil,leucovorin,and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer显示文摘 | Bokemeyer C Bondarenko I Makhson A | | 0，，5： | 1 |
| 15 | Fluorouracil,leucovorin,and oxaliplatin with and without cetuximab in the firstline treatment of metastatic colorectal cancer显示文摘 | Bokemeyer C Bondarenko I Makhson A | | 0，，： | 1 |
| 16 | Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2009 | J Clin Oncol2009，27，5： | 1 |
| 17 | Fluorouracil, leucovorin,and oxaliplatin with and without cetuximab in the first- hne treatment of metastatic colorectal cancer 显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2009 | J Clin Oncol2009，27，5： | 1 |
| 18 | Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer 显示文摘 | BOKEMEYER C BONDARENKO L MAKHSON A eta| | 2009 | J Clin 0ncol2009，27，5： | 1 |
| 19 | Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC): OPUS, a randomized phase Ⅱ study显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2007 | J Clin Oncol2007，25，18： | 1 |
| 20 | Fluorouracil,leucovorin,and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer显示文摘 | Bokemeyer C Bondarenko I Makhson A | 2009 | J Clin Oncol2009，27，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员